| Primary |
| Renal Transplant |
42.5% |
| Immunosuppression |
14.9% |
| Hypertension |
7.4% |
| Pancreas Transplant |
6.2% |
| Stem Cell Transplant |
4.4% |
| Pemphigus |
3.9% |
| Prophylaxis |
3.4% |
| Prophylaxis Against Transplant Rejection |
2.7% |
| Immunosuppressant Drug Therapy |
2.2% |
| Liver Transplant |
1.9% |
| Graft Versus Host Disease |
1.8% |
| Transplant |
1.7% |
| Lung Transplant |
1.5% |
| Infection Prophylaxis |
1.0% |
| Osteoporosis |
0.9% |
| Systemic Lupus Erythematosus |
0.9% |
| Antifungal Prophylaxis |
0.7% |
| Nephropathy |
0.7% |
| Renal And Pancreas Transplant |
0.7% |
| Cardiovascular Event Prophylaxis |
0.6% |
|
| Diarrhoea |
9.2% |
| Renal Failure |
9.2% |
| Renal Failure Acute |
8.6% |
| Pyrexia |
6.6% |
| Respiratory Failure |
5.9% |
| Vomiting |
5.9% |
| Weight Decreased |
5.9% |
| Renal Impairment |
5.3% |
| Urinary Tract Infection |
5.3% |
| Urosepsis |
4.6% |
| Pancytopenia |
3.9% |
| Pneumonia |
3.9% |
| Agranulocytosis |
3.3% |
| Cytolytic Hepatitis |
3.3% |
| Cytomegalovirus Infection |
3.3% |
| Kidney Transplant Rejection |
3.3% |
| Leukopenia |
3.3% |
| Surgery |
3.3% |
| Wound Dehiscence |
3.3% |
| Acute Hepatic Failure |
2.6% |
|
| Secondary |
| Renal Transplant |
38.8% |
| Immunosuppression |
15.2% |
| Prophylaxis Against Transplant Rejection |
7.1% |
| Hypertension |
5.8% |
| Product Used For Unknown Indication |
5.5% |
| Prophylaxis |
4.0% |
| Stem Cell Transplant |
3.8% |
| Graft Versus Host Disease |
3.6% |
| Pemphigus |
2.6% |
| Prophylaxis Against Graft Versus Host Disease |
1.8% |
| Liver Transplant |
1.7% |
| Antifungal Prophylaxis |
1.6% |
| Lung Transplant |
1.3% |
| Immunosuppressant Drug Therapy |
1.3% |
| Nephrotic Syndrome |
1.2% |
| Tuberculosis |
1.1% |
| Chronic Graft Versus Host Disease |
1.0% |
| Drug Use For Unknown Indication |
0.9% |
| Hyperparathyroidism |
0.9% |
| Meningitis |
0.8% |
|
| Viral Pharyngitis |
8.7% |
| Vomiting |
8.7% |
| Pneumocystis Jiroveci Pneumonia |
6.7% |
| Renal Failure |
6.7% |
| Pancytopenia |
6.0% |
| Pyrexia |
6.0% |
| Pharyngitis |
5.4% |
| Proteinuria |
5.4% |
| Renal Failure Acute |
5.4% |
| Sepsis |
5.4% |
| Renal Transplant |
4.7% |
| Upper Respiratory Tract Infection |
4.7% |
| Urinary Retention |
4.7% |
| Septic Shock |
3.4% |
| Stent Placement |
3.4% |
| Toxicity To Various Agents |
3.4% |
| White Blood Cell Count Increased |
3.4% |
| Agranulocytosis |
2.7% |
| Bronchiectasis |
2.7% |
| Femur Fracture |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
24.1% |
| Renal Transplant |
12.8% |
| Immunosuppression |
10.4% |
| Immunosuppressant Drug Therapy |
9.9% |
| Drug Use For Unknown Indication |
7.5% |
| Prophylaxis Against Transplant Rejection |
5.9% |
| Hypertension |
3.3% |
| Infection Prophylaxis |
2.8% |
| Acute Graft Versus Host Disease |
2.6% |
| Blood Pressure |
2.3% |
| Prophylaxis Against Graft Versus Host Disease |
2.3% |
| Transplant Rejection |
2.1% |
| Acute Leukaemia |
1.9% |
| Renal Failure Chronic |
1.9% |
| Heart Transplant |
1.7% |
| Liver Transplant |
1.7% |
| Pain |
1.7% |
| Prophylaxis |
1.7% |
| Systemic Lupus Erythematosus |
1.7% |
| Rhodococcus Infection |
1.6% |
|
| Renal Impairment |
9.0% |
| Vomiting |
7.7% |
| Weight Decreased |
7.7% |
| Weight Increased |
7.7% |
| Biliary Neoplasm |
6.4% |
| Transplant Failure |
6.4% |
| Drug Ineffective |
5.1% |
| Aplasia Pure Red Cell |
3.8% |
| Arthralgia |
3.8% |
| Deep Vein Thrombosis |
3.8% |
| Drug Interaction |
3.8% |
| Fungal Infection |
3.8% |
| Inflammation |
3.8% |
| Kidney Transplant Rejection |
3.8% |
| Metabolic Acidosis |
3.8% |
| Myopathy |
3.8% |
| Renal Failure |
3.8% |
| Renal Failure Acute |
3.8% |
| Serum Sickness |
3.8% |
| Therapeutic Response Decreased |
3.8% |
|
| Interacting |
| Immunosuppression |
40.0% |
| Hyperlipidaemia |
20.0% |
| Hypertension |
20.0% |
| Renal Transplant |
20.0% |
|
|
